Search Results - "Snanoudj, R."

Specificity of Histological Markers of Long‐Term CNI Nephrotoxicity in Kidney‐Transplant Recipients Under Low‐Dose Cyclosporine Therapy by Snanoudj, R., Royal, V., Elie, C., Rabant, M., Girardin, C., Morelon, E., Kreis, H., Fournet, J.‐C., Noël, L.‐H., Legendre, C.

“…The specificity of chronic histological lesions induced by calcineurin inhibitors (CNI) is often questioned, but few studies have directly compared long‐term…”
Get full text

Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney Recipients by Rabant, M., Amrouche, L., Morin, L., Bonifay, R., Lebreton, X., Aouni, L., Benon, A., Sauvaget, V., Le Vaillant, L., Aulagnon, F., Sberro, R., Snanoudj, R., Mejean, A., Legendre, C., Terzi, F., Anglicheau, D.

“…We monitored the urinary C‐X‐C motif chemokine (CXCL)9 and CXCL10 levels in 1722 urine samples from 300 consecutive kidney recipients collected during the…”
Get full text

Intensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study by Canaud, G., Zuber, J., Sberro, R., Royale, V., Anglicheau, D., Snanoudj, R., Gaha, K., Thervet, E., Lefrère, F., Cavazzana‐Calvo, M., Noël, L.‐H., Méjean, A., Legendre, Ch, Martinez, F.

“…No treatment has consistently induced long‐term remission of proteinuria in adult patients with focal segmental glomerulosclerosis (FSGS) recurrence after…”
Get full text

Outcome of Kidney Transplantations Performed With Preformed Donor‐Specific Antibodies of Unknown Etiology by Sicard, A., Amrouche, L., Suberbielle, C., Carmagnat, M., Candon, S., Thervet, E., Delahousse, M., Legendre, C., Chatenoud, L., Snanoudj, R.

“…The detection of preformed donor‐specific alloantibodies (DSA) with multiplex‐bead arrays has led to the common observation that individuals without a history…”
Get full text

Bortezomib as the Sole Post‐Renal Transplantation Desensitization Agent Does Not Decrease Donor‐Specific Anti‐HLA Antibodies by Sberro‐Soussan, R., Zuber, J., Suberbielle‐Boissel, C., Candon, S., Martinez, F., Snanoudj, R., Rabant, M., Pallet, N., Nochy, D., Anglicheau, D, Leruez, M., Loupy, A., Thervet, E., Hermine, O., Legendre, C.

“…Persistence of donor‐specific anti‐HLA antibodies (DSA) associated with antibody‐mediated graft injuries following kidney transplantation predicts evolution…”
Get full text

Risk of Antibody‐Mediated Rejection in Kidney Transplant Recipients With Anti‐HLA‐C Donor‐Specific Antibodies by Aubert, O., Bories, M.‐C., Suberbielle, C., Snanoudj, R., Anglicheau, D., Rabant, M., Martinez, F., Scemla, A., Legendre, C., Sberro‐Soussan, R.

“…Anti‐HLA donor‐specific antibodies (DSAs) cause acute and chronic antibody‐mediated rejection (AMR). However, the clinical relevance of anti‐HLA‐C antibodies…”
Get full text

Sirolimus May Reduce Fertility in Male Renal Transplant Recipients by Zuber, J., Anglicheau, D., Elie, C., Bererhi, L., Timsit, M‐O., Mamzer‐Bruneel, M‐F., Ciroldi, M., Martinez, F., Snanoudj, R., Hiesse, C., Kreis, H., Eustache, F., Laborde, K., Thervet, E., Legendre, C.

“…Assessment of sex hormones in organ transplant recipients suggests that sirolimus may impair testicular function. The aim of this study was to evaluate the…”
Get full text

Dramatic Improvement of Severe Cryptococcosis‐Induced Immune Reconstitution Syndrome With Adalimumab in a Renal Transplant Recipient by Scemla, A., Gerber, S., Duquesne, A., Parize, P., Martinez, F., Anglicheau, D., Snanoudj, R., Zuber, M., Bougnoux, M.‐E., Legendre, C., Lortholary, O.

“…In solid organ transplant recipients, immune reconstitution inflammatory syndrome (IRIS) is a rare complication of cryptococcosis, which may require steroids…”
Get full text

Incidence, Risk Factors and Clinical Consequences of Neutropenia Following Kidney Transplantation: A Retrospective Study by Zafrani, L., Truffaut, L., Kreis, H., Etienne, D., Rafat, C., Lechaton, S., Anglicheau, D., Zuber, J., Ciroldi, M., Thervet, E., Snanoudj, R., Mamzer, M. F., Martinez, F., Timsit, M.O., Bergougnoux, L., Legendre, C.

“…Neutropenic episodes in kidney transplant patients are poorly characterized. In this retrospective study, neutropenia was experienced by 112/395 patients (28%)…”
Get full text

Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS) by Canaud, Guillaume, Dion, Daniel, Zuber, Julien, Gubler, Marie-Claire, Sberro, Rebecca, Thervet, Eric, Snanoudj, Renaud, Charbit, Marina, Salomon, Rémi, Martinez, Frank, Legendre, Christophe, Noel, Laure-Helene, Niaudet, Patrick

“…Introduction. Recurrence of nephrotic-range proteinuria in patients with idiopathic nephrotic syndrome (INS) and focal and segmental glomerulosclerosis (FSGS)…”
Get full text

Severe infections requiring intensive care unit admission in kidney transplant recipients: impact on graft outcome by Bige, N., Zafrani, L., Lambert, J., Peraldi, M.-N., Snanoudj, R., Reuter, D., Legendre, C., Chevret, S., Lemiale, V., Schlemmer, B., Azoulay, E., Canet, E.

“…Background Kidney transplant recipients are at risk for life‐threatening infections, which may affect the long‐term prognosis. Methods We retrospectively…”
Get full text

Five‐Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study by Lebranchu, Y., Snanoudj, R., Toupance, O., Weestel, P.‐F., de Ligny, B. Hurault, Buchler, M., Rerolle, J.‐P., Thierry, A., Moulin, B., Subra, J.‐F., Deteix, P., Pogamp, P. Le, Finzi, L., Etienne, I.

“…Calcineurin inhibitors improve acute rejection rates and short‐term graft survival in renal transplantation, but their continuous use may be deleterious. We…”
Get full text

Risk Factors and Long‐Term Outcome of Transplant Renal Artery Stenosis in Adult Recipients After Treatment by Percutaneous Transluminal Angioplasty by Audard, V., Matignon, M., Hemery, F., Snanoudj, R., Desgranges, P., Anglade, M. C., Kobeiter, H., Durrbach, A., Charpentier, B., Lang, P., Grimbert, P.

“…Transplant renal artery stenosis (TRAS) is a common complication of kidney transplantation but attempts to identify predisposing risk factors for TRAS have…”
Get full text

Donor‐Estimated GFR as an Appropriate Criterion for Allocation of ECD Kidneys into Single or Dual Kidney Transplantation by Snanoudj, R., Rabant, M., Timsit, M. O., Karras, A., Savoye, E., Tricot, L., Loupy, A., Hiesse, C., Zuber, J., Kreis, H., Martinez, F., Thervet, E., Méjean, A., Lebret, T., Legendre, C., Delahousse, M.

“…It has been suggested that dual kidney transplantation (DKT) improves outcomes for expanded criteria donor (ECD) kidneys. However, no criteria for allocation…”
Get full text

Late-onset post-transplantation lymphoproliferative disorders after kidney transplantation: a monocentric study over three decades by Michonneau, David, Suarez, Felipe, Lambert, Jérôme, Adam, Julien, Brousse, Nicole, Canioni, Danielle, Anglicheau, Dany, Martinez, Frank, Snanoudj, Renaud, Legendre, Christophe, Hermine, Olivier, Mamzer-Bruneel, Marie-France

“…Late-onset post-transplantation lymphoproliferative disorders (PTLDs) occur 1 year after transplantation and are associated with poor prognosis. Initial…”
Get full text

Recurrence of HUS Due to CD46/MCP Mutation After Renal Transplantation: A Role for Endothelial Microchimerism by Frémeaux‐Bacchi, V., Arzouk, N., Ferlicot, S., Charpentier, B., Snanoudj, R., Dürrbach, A.

“…Mutations in the gene of the membrane cofactor protein (MCP/CD46), a complement regulatory protein, were recently described as a cause of hemolytic uremic…”
Get full text

Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation by Snanoudj, Renaud, Durrbach, Antoine, Gauthier, Eric, Adams, David, Samuel, Didier, Ferlicot, Sophie, Bedossa, Pierre, Prigent, Alain, Bismuth, Henri, Charpentier, Bernard

“…Background. Familial amyloid polyneuropathy (FAP) is an autosomal dominant disease caused by a point mutation in the gene encoding transthyretin, which is…”
Get full text

Nephrotoxicity of calcineurin inhibitors: presentation, diagnostic problems and risk factors by Snanoudj, R, Rabant, M, Royal, V, Pallet, N, Noël, L-H, Legendre, C

“…Nephrotoxicity of calcineurin inhibitors (CNIs) is an acute, reversible and chronic, irreversible pathology. Histologically, acute nephrotoxicity manifests as…”
Get full text

Single-Center experience with cyclosporine therapy for kidney transplantation: analysis of a Twenty-Year period in 1200 patients by Snanoudj, R, Kriaa, F, Arzouk, N, Beaudreuil, S, Hiesse, C, Durrbach, A, Charpentier, B

“…Since the introduction of cyclosporine (CyA) in our center in February 1983, 1267 kidney transplant patients have received an immunosuppressive regimen based…”
Get full text

Kidney transplantation at Necker Hospital: the most recent 5-year period (2004-2009) by Legendre, Ch, Kreis, H, Martinez, F, Snanoudj, R, Mamzer, M F, Sberro, R, Bererhi, L, Anglicheau, D, Zuber, J, Loupy, A, Thervet, E, Pallet, N, Sartorius, A, Bertrand, D, Canaud, G, Noël, L H, Rabant, M, Timsit, M O, Méjean, A

“…The results of our last 5 years activity in kidney transplantation clearly show that it is possible to perform high-risk transplantations with very acceptable…”
Get more information